Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic ResponsesJonathan B. Mitchem, David G. DeNardo, Larisa Belaygorod et al.|Cancer Research|2012Cited by 941
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Victor E. Velculescu, Jillian Phallen et al.|Nature Communications|2015Cited by 484
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancerRoheena Z. Panni, David C. Linehan|Cancer Immunology Immunotherapy|2014Cited by 216